Kyle McElyea

Statistics

Publications

Citations

237

H-Index

Active since

2015

Affiliations

Indiana University – Purdue University Indianapolis(Current)

Indiana University School of Medicine

Indiana University Health

Richard L. Roudebush VA Medical Center

Kyle McElyea is an author at Indiana University – Purdue University Indianapolis specializing in molecular oncology, medicine, and cancer cell signaling.

ORCID

Publications per year

2015–2018

Publications

A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with <i>FGFR3</i> Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157

Noah M. Hahn, Trinity J. Bivalacqua, Ashley E. Ross et al. · Clinical Cancer Research · 2016 · 71 citations · Full text

Medicine, Oncology, Pharmacology +14

Critical role of phosphorylation of serine 165 of YBX1 on the activation of NF-κB in colon cancer

Lakshmi Prabhu, Rasika Mundade, Benlian Wang et al. · Oncotarget · 2015 · 55 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

Applying Small Molecule Signal Transducer and Activator of Transcription-3 (STAT3) Protein Inhibitors as Pancreatic Cancer Therapeutics

Carolyn C. Arpin, Stephen Mac, Yanlin Jiang et al. · Molecular Cancer Therapeutics · 2016 · 39 citations · Full text

Medicine, Oncology, Pharmacology +17

Dependence receptor UNC5A restricts luminal to basal breast cancer plasticity and metastasis

Maria B. Padua, Poornima Bhat‐Nakshatri, Manjushree Anjanappa et al. · Breast Cancer Research · 2018 · 25 citations · Full text

Medicine, Cancer Biology, Molecular Biology +14

Early-Stage Metastasis Requires Mdm2 and Not p53 Gain of Function

Paula M. Hauck, Eric R. Wolf, David J. Olivos et al. · Molecular Cancer Research · 2017 · 24 citations · Full text

Medicine, Cancer Biology, Cell Biology +17

1–5 of 6